Skip to main content
. 2022 Jan 6;24(1):23–30. doi: 10.1007/s11886-021-01621-0

Fig. 2.

Fig. 2

Kaplan–Meier survival curve results of the RHAPSODY phase III trial [8••] A pain score and C-reactive protein levels over time and B freedom from recurrent pericarditis events (reprinted with permission from [8••];

copyright 2021. Massachusetts Medical Society)